ATE462476T1 - Verbesserte formulierung für hautbleichmittel - Google Patents

Verbesserte formulierung für hautbleichmittel

Info

Publication number
ATE462476T1
ATE462476T1 AT04704302T AT04704302T ATE462476T1 AT E462476 T1 ATE462476 T1 AT E462476T1 AT 04704302 T AT04704302 T AT 04704302T AT 04704302 T AT04704302 T AT 04704302T AT E462476 T1 ATE462476 T1 AT E462476T1
Authority
AT
Austria
Prior art keywords
skin
improved skin
skin bleaching
bleaching formulation
formulation
Prior art date
Application number
AT04704302T
Other languages
English (en)
Inventor
Xina Nair
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE462476T1 publication Critical patent/ATE462476T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04704302T 2003-02-03 2004-01-22 Verbesserte formulierung für hautbleichmittel ATE462476T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44449603P 2003-02-03 2003-02-03
PCT/IB2004/000240 WO2004069221A1 (en) 2003-02-03 2004-01-22 Improved formulation for skin-lightening agents

Publications (1)

Publication Number Publication Date
ATE462476T1 true ATE462476T1 (de) 2010-04-15

Family

ID=32850872

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04704302T ATE462476T1 (de) 2003-02-03 2004-01-22 Verbesserte formulierung für hautbleichmittel

Country Status (9)

Country Link
US (1) US20060257340A1 (de)
EP (1) EP1592397B1 (de)
JP (1) JP2006516605A (de)
AT (1) ATE462476T1 (de)
BR (1) BRPI0407193A (de)
CA (1) CA2513949A1 (de)
DE (1) DE602004026272D1 (de)
MX (1) MXPA05008243A (de)
WO (1) WO2004069221A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
FR2930145B1 (fr) * 2008-04-16 2012-08-03 Fabre Pierre Dermo Cosmetique Utilisation d'un extrait de myrte comme depigmentant.
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
GB0922200D0 (en) * 2009-12-21 2010-02-03 Xyrex Ltd Composition, use and method of preparation thereof
KR101666372B1 (ko) * 2010-05-25 2016-10-14 시므라이즈 아게 피부 및/또는 모발 라이트닝 활성제로서 멘틸 카바메이트 화합물
US20130011347A1 (en) * 2011-07-07 2013-01-10 Paul Robert Tanner Personal Care Compositions With Improved Solubility of a Solid Cosmetic Active
CA2902506A1 (en) 2013-03-08 2014-09-12 Unilever Plc Resorcinol compounds for dermatological use
FR3045604B1 (fr) * 2015-12-18 2018-01-26 L'oreal Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711904A (en) * 1986-08-04 1987-12-08 Luzzi Louis A Method of treating skin disorders
HUT74560A (en) * 1991-10-16 1997-01-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
US5824326A (en) * 1997-06-27 1998-10-20 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Activity enhancement of ferulic acid with dimethyl isosorbride in cosmetic compositions
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
US6878381B2 (en) * 1999-03-22 2005-04-12 Pfizer, Inc Resorcinol composition
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
EP1539098B1 (de) * 2002-09-20 2011-08-10 Fmc Corporation Kosmetische zusammensetzung mit mikrokristalliner cellulose
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof

Also Published As

Publication number Publication date
US20060257340A1 (en) 2006-11-16
MXPA05008243A (es) 2005-10-05
WO2004069221A1 (en) 2004-08-19
EP1592397A1 (de) 2005-11-09
CA2513949A1 (en) 2004-08-19
DE602004026272D1 (de) 2010-05-12
BRPI0407193A (pt) 2006-02-14
JP2006516605A (ja) 2006-07-06
EP1592397B1 (de) 2010-03-31

Similar Documents

Publication Publication Date Title
MX2007006539A (es) Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel.
MX353841B (es) Composiciones antimicrobianas y metodos de uso.
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
ATE448777T1 (de) Mittel für die transdermale verabreichung von nikotin
CR8428A (es) Agente endoparasiticidas para la administracion topica
PE20142371A1 (es) Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico
ECSP077299A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3-trifluorometil-fenil)-ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos
DE602005001170D1 (de) Kosmetisches Mittel Formulierungskit
IN2012DN02817A (de)
DE69921318D1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
EA201001283A1 (ru) Комбинация витамина d и 25-гидроксивитамина d3
WO2006007487A3 (en) Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
EA200901443A1 (ru) Фунгицидные смеси
MY158428A (en) Topical composition for the treatment of actinic keratosis
BRPI0920355B8 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
BR112012014737A2 (pt) calconas como realçador de agentes antimicrobianos
BRPI0516666A (pt) 2-alcóxi-3,4,5-trihidróxi-alquilamidas, o respectivo preparo, composições que as contém e a respectiva utilização
EA200901406A1 (ru) Чистящий блок для туалета
ATE462476T1 (de) Verbesserte formulierung für hautbleichmittel
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
GT200600121A (es) Novedosos derivados de triazolopirimidina
CY1109507T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια
BRPI0608287A2 (pt) agente endoparasiticida
AR057648A1 (es) Composicion de metaflumizona para la administracion topica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties